Patent · US Expired

Compounds that inhibit factor Xa activity

US7256194B2 · kind B2 · utility

0Cited by

1References

10Claims

0Family size

Assignee

Morphochem GmbH · DE

Inventors

Sven Nerdinger · Birkenfeld, DE
Thilo Fuchs · Hersbruck, DE
Katrin Illgen · Birkenfeld, DE
Robert Eckl · Munich, DE

Key dates

Filing date	Feb 22, 2002
Grant date	Aug 14, 2007
Priority date	—
Expiry date	Oct 26, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D209/16
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds of the Formulaor a pharmaceutically acceptable salt, solvate, hydrate or formulation thereof. These compounds can be used for the inhibition of Factor Xa and for the treatment and/or prevention of diseases that are mediated by Factor Xa activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.